Claudia Koch
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claudia Koch has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Andrei Anghel
Department of Biochemistry "Victor Babes" Univeristy of Medicine and Pharmacy Timisoara, Romania
1 shared publication - Andrei Emanuel Grigorescu
Department of Cardiology "Victor Babes" University of Medicine and Pharmacy Timisoara, Research Center of The Institute of Cardiovascular and Heart Disease of Timisoara, Division of Cardiovascular Surgery Insitute for Cardiovascular Diseases Timisoara, Doctoral School Medicine - Pharmacy "Victor Babes" University of Medicine and Pharmacy Timisoara, Romania
1 shared publication - Delia Savescu
Laboratory Department, Children Emergency Hospital “Louis Turcanu” Timișoara, European Hemophilia Treatment Centre, 300011 Timișoara, Romania
1 shared publication - Florin George Horhat
Center for Translational Research and Systems Medicine, “Victor Babes” University of Medicine and Pharmacy Timisoara, 300041 Timisoara, Romania
1 shared publication - Horea Feier
Department VI Cardiology-Cardiovascular Surgery Clinic, “Victor Babes” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication
Latest Publications
- Open Access
Von Willebrand Factor Dynamics in Patients with Aortic Stenosis Undergoing Surgical and Transcatheter Valve Replacement
Aortic stenosis (AS) is a prevalent valvular disorder that poses a significant burden on healthcare systems due to its debilitating symptoms and high mortality rates if left untreated. Surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) are the primary interventions for severe AS, but perioperative complications such as bleeding remain a concern. Von Willebrand factor (VWF), a crucial player in hemostasis, is known to be altered in AS and may contribute to the hemostatic imbalance observed in these patients. This prospective study aimed to investigate the association between prosthetic valve type, size, and postprocedural VWF levels in patients undergoing aortic valve replacement (AVR) for severe AS. This study involved 39 consecutive patients diagnosed with severe AS who underwent SAVR or TAVR. By elucidating the VWF dynamics associated with different prosthetic valves, this study sought to provide valuable insights into personalized valve selection and perioperative management strategies.
Open AccessVon Willebrand Factor Dynamics in Patients with Aortic Stenosis Undergoing Surgical and Transcatheter Valve Replacement
Aortic stenosis (AS) is a prevalent valvular disorder that poses a significant burden on healthcare systems due to its debilitating symptoms and high mortality rates if left untreated. Surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) are the primary interventions for severe AS, but perioperative complications such as bleeding remain a concern. Von Willebrand factor (VWF), a crucial player in hemostasis, is known to be altered in AS and may contribute to the hemostatic imbalance observed in these patients. This prospective study aimed to investigate the association between prosthetic valve type, size, and postprocedural VWF levels in patients undergoing aortic valve replacement (AVR) for severe AS. This study involved 39 consecutive patients diagnosed with severe AS who underwent SAVR or TAVR. By elucidating the VWF dynamics associated with different prosthetic valves, this study sought to provide valuable insights into personalized valve selection and perioperative management strategies.